We are live on
!
Find out more
LSV Asset Management Portfolio holdings
AUM
$55.1B
Turnover
9.67%
1-Year Est. Return
45.38%
This Fund
S&P 500
This Quarter
Est. Return
+3.85%
1 Year Est. Return
+45.38%
3 Year Est. Return
+99.45%
5 Year Est. Return
+122.42%
10 Year Est. Return
+379.58%
AUM
$42.9B
AUM Growth
+$349M
(+0.82%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.38%
Holding
921
New
30
Increased
236
Reduced
381
Closed
55
Avg Time Held
0.7
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$516M |
| 2 |
Exelon
EXC
|
+$216M |
| 3 |
Pfizer
PFE
|
+$145M |
| 4 |
Baxter International
BAX
|
+$52.2M |
| 5 |
Intel
INTC
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$189M |
| 2 |
Walgreens Boots Alliance
WBA
|
+$162M |
| 3 |
Merck
MRK
|
+$116M |
| 4 |
Abbott
ABT
|
+$79.3M |
| 5 |
HAR
Harman International Industries
HAR
|
+$75.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.88% |
| 2 | Technology | 15.18% |
| 3 | Energy | 12.54% |
| 4 | Healthcare | 12.19% |
| 5 | Industrials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Lockheed Martin
LMT
$127B
| $198M | 0.46% |
1,215,644
-467,285
| -28% | -$73.4M |
2013 Q2
3 quarters
|
|
77
CF Industries
CF
$18.3B
| $196M | 0.46% |
3,760,800
+925
| +0% | +$45K |
2013 Q2
3 quarters
|
|
78
Hartford Financial Services
HIG
$36.5B
| $194M | 0.45% |
5,486,847
-128,785
| -2% | -$4.48M |
2013 Q2
3 quarters
|
|
79
KeyCorp
KEY
$21.3B
| $193M | 0.45% |
13,555,393
-236,037
| -2% | -$3.16M |
2013 Q2
3 quarters
|
|
80
DELISTED
CHUBB CORPORATION
CB
| $187M | 0.44% |
2,095,304
+59,988
| +3% | +$5.25M |
2013 Q2
3 quarters
|
|
81
DELISTED
PARTNERRE LTD
PRE
| $186M | 0.43% |
1,795,091
-75,993
| -4% | -$7.59M |
2013 Q2
3 quarters
|
|
82
Truist Financial
TFC
$57.9B
| $186M | 0.43% |
4,619,329
-62,450
| -1% | -$2.39M |
2013 Q2
3 quarters
|
|
83
MetLife
MET
$64.4B
| $185M | 0.43% |
3,926,694
-75,460
| -2% | -$3.47M |
2013 Q2
3 quarters
|
|
84
Eastman Chemical
EMN
$7.12B
| $181M | 0.42% |
2,103,467
-9,801
| -0.5% | -$803K |
2013 Q2
3 quarters
|
|
85
DELISTED
TEGNA Inc
TGNA
| $174M | 0.41% |
12,049,427
-1,126,497
| -9% | -$16.8M |
2013 Q2
3 quarters
|
|
86
Medtronic
MDT
$121B
| $173M | 0.4% |
2,810,138
-75,760
| -3% | -$4.41M |
2013 Q2
3 quarters
|
|
|
VR
87
DELISTED
Validus Hold Ltd
VR
| $168M | 0.39% |
4,465,925
+307,678
| +7% | +$11.4M |
2013 Q2
3 quarters
|
|
|
LXK
88
DELISTED
Lexmark Intl Inc
LXK
| $166M | 0.39% |
3,582,214
-34,024
| -0.9% | -$1.37M |
2013 Q2
3 quarters
|
|
89
Cigna
CI
$79.7B
| $165M | 0.38% |
1,965,860
-10,053
| -0.5% | -$828K |
2013 Q2
3 quarters
|
|
90
United Therapeutics
UTHR
$22.8B
| $164M | 0.38% |
1,744,650
-726,463
| -29% | -$74.3M |
2013 Q2
3 quarters
|
|
|
DNY
91
DELISTED
DONNELLEY R R & SONS CO
DNY
| $153M | 0.36% |
8,540,423
+210,140
| +3% | +$3.76M |
2013 Q2
3 quarters
|
|
92
APA Corp
APA
$17.1B
| $152M | 0.35% |
1,831,327
-77,074
| -4% | -$6.32M |
2013 Q2
3 quarters
|
|
93
AbbVie
ABBV
$505B
| $152M | 0.35% |
2,947,885
-273,566
| -8% | -$13.8M |
2013 Q2
3 quarters
|
|
94
Cabot Corp
CBT
$3.82B
| $141M | 0.33% |
2,395,731
-48,188
| -2% | -$2.53M |
2013 Q2
3 quarters
|
|
95
Unum
UNM
$14.7B
| $140M | 0.33% |
3,964,213
-305,737
| -7% | -$10.4M |
2013 Q2
3 quarters
|
|
96
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $134M | 0.31% |
2,541,610
+228,274
| +10% | +$11.9M |
2013 Q2
3 quarters
|
|
97
Aflac
AFL
$59.9B
| $133M | 0.31% |
4,224,454
-361,346
| -8% | -$11.5M |
2013 Q2
3 quarters
|
|
98
Regions Financial
RF
$23.4B
| $132M | 0.31% |
11,908,184
-447,799
| -4% | -$4.72M |
2013 Q2
3 quarters
|
|
99
Edison International
EIX
$21.5B
| $130M | 0.3% |
2,299,520
+837,620
| +57% | +$41.7M |
2013 Q2
3 quarters
|
|
|
SCG
100
DELISTED
Scana
SCG
| $130M | 0.3% |
2,525,677
+464,977
| +23% | +$22.4M |
2013 Q3
2 quarters
|
|
Similar funds
LSV Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, LSV Asset Management held 921 positions worth $42.9B, up 0.82% from $42.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
LSV Asset Management's Q1 2014 filing shows 30 new, 236 increased, 381 reduced and 55 closed positions. Its largest new stake was Chemed: 283,612 shares worth $25.4M. The largest sale was St Jude Medical, an estimated $189M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Technology and Energy.
- LSV Asset Management's largest Q1 2014 buy was Chemed: 283,612 shares worth $25.4M.
- LSV Asset Management added most to AT&T in Q1 2014, an estimated $516M increase.
- LSV Asset Management's biggest Q1 2014 reduction was St Jude Medical, cutting an estimated $189M.
- LSV Asset Management fully exited Harman International Industries in Q1 2014, selling an estimated $75.3M.
- LSV Asset Management's ten largest holdings make up 17% of its $42.9B portfolio in Q1 2014.
- LSV Asset Management opened 30 new positions and closed 55 in Q1 2014.
- LSV Asset Management's portfolio value rose 0.82% quarter-over-quarter to $42.9B.
Based on LSV Asset Management's 13F filing for Q1 2014, filed 29 Apr 2014.